Improving Drug Safety in Nursing Home Residents with Chronic Renal Insufficiency
DOI: 10.3238/zfa.2018.0058-0063german translation / full article
Background: A high number of nursing home residents (NHR) is affected by chronic renal insufficiency. Many different professional groups are involved in the medical treatment of this vulnerable patient group. Interventions improving safety of drug therapy have to take this into account. The aim of this study is to develop appropriate interventions improving safety of drug therapy for NHR with renal insufficiency.Methods: The data base are focus group interviews from the study “Inappropriate Medication in patients with REnal insufficiency in Nursing homes” (IMREN) with family practitioners (FPs), nephrologists, nursing staff and pharmacists. Based on the transcripts, potential interventions for safety of drug therapy were derived by qualitative content analysis. In a cross-sectional study, the relevance and feasibility of the interventions were judged by nursing staff, FPs and pharmacists.Results: Twelve potential interventions improving safety of drug therapy were derived. Nursing staff (n = 9), FPs (n = 8) and pharmacists (n = 5) took part in the survey (response: 22/71 = 31 %). Nine possible interventions were judged as relevant for routine care, seven of them were rated as easy to implement. The interventions concern “drug prescription”, “home admission”, “structure of the medication plan/patient record” and “systematic reduction of medication”.Conclusions: There are different approaches to improve safety of drug therapy in nursing home residents with chronic renal insufficiency. They are mostly applicable to residents in general.